By Chelsea Naso ( April 30, 2014, 2:13 PM EDT) -- An Indian court on Friday halted Sun Pharmaceuticals Inc.'s $3.2 billion all-stock takeover of struggling rival Ranbaxy Laboratories Ltd., following a petition lodged earlier last week by two Sun Pharma shareholders alleging the companies had violated the country's insider trading rules....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.